1. Home
  2. ICCC vs FSI Comparison

ICCC vs FSI Comparison

Compare ICCC & FSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICCC
  • FSI
  • Stock Information
  • Founded
  • ICCC 1982
  • FSI 1991
  • Country
  • ICCC United States
  • FSI Canada
  • Employees
  • ICCC N/A
  • FSI N/A
  • Industry
  • ICCC Biotechnology: Pharmaceutical Preparations
  • FSI Recreational Games/Products/Toys
  • Sector
  • ICCC Health Care
  • FSI Consumer Discretionary
  • Exchange
  • ICCC Nasdaq
  • FSI Nasdaq
  • Market Cap
  • ICCC 60.1M
  • FSI 55.6M
  • IPO Year
  • ICCC 1987
  • FSI 1999
  • Fundamental
  • Price
  • ICCC $6.71
  • FSI $5.54
  • Analyst Decision
  • ICCC
  • FSI
  • Analyst Count
  • ICCC 0
  • FSI 0
  • Target Price
  • ICCC N/A
  • FSI N/A
  • AVG Volume (30 Days)
  • ICCC 41.8K
  • FSI 18.1K
  • Earning Date
  • ICCC 08-12-2025
  • FSI 08-13-2025
  • Dividend Yield
  • ICCC N/A
  • FSI 1.80%
  • EPS Growth
  • ICCC N/A
  • FSI N/A
  • EPS
  • ICCC N/A
  • FSI 0.18
  • Revenue
  • ICCC $27,302,766.00
  • FSI $36,483,680.00
  • Revenue This Year
  • ICCC N/A
  • FSI $21.91
  • Revenue Next Year
  • ICCC N/A
  • FSI $42.35
  • P/E Ratio
  • ICCC N/A
  • FSI $30.52
  • Revenue Growth
  • ICCC 28.29
  • FSI N/A
  • 52 Week Low
  • ICCC $3.34
  • FSI $1.65
  • 52 Week High
  • ICCC $7.60
  • FSI $7.24
  • Technical
  • Relative Strength Index (RSI)
  • ICCC 49.68
  • FSI 77.89
  • Support Level
  • ICCC $5.63
  • FSI $4.77
  • Resistance Level
  • ICCC $7.14
  • FSI $5.00
  • Average True Range (ATR)
  • ICCC 0.64
  • FSI 0.19
  • MACD
  • ICCC -0.06
  • FSI 0.11
  • Stochastic Oscillator
  • ICCC 42.58
  • FSI 100.00

About ICCC ImmuCell Corporation

ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.

About FSI Flexible Solutions International Inc. (CDA)

Flexible Solutions International Inc develops, manufactures, and markets specialty chemicals that slow the evaporation of water. Its business is organized into two segments: Energy and Water Conservation Products and Biodegradable Polymers. It offers a liquid swimming pool blanket under the WATERSAVR brand, which saves energy and water by inhibiting evaporation from the pool surface, and a chemical product called HEATSAV for use in swimming pools and spas to slow water evaporation. The firm also manufactures and markets water-soluble chemicals utilizing thermal polyaspartate biopolymers. It generates the majority of its revenues from the export of its products to international markets.

Share on Social Networks: